Toggle Offcanvas
...
 
Oxycodone Tenders

Oxycodone Tenders

View Oxycodone tenders, RFPs and contracts. Bid on readily available Oxycodone tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Oxycodone tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Oxycodone.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Oxycodone market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Oxycodone tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

18 Live Notices for Oxycodone Tenders

Showing 1 to 18

* Price Registration * Price Registration For The Provision Of Legal Action - Oxycodone, Hydrochloride 10 Mg Oxycontin; Lawsuit - Quetiapina, Hemifumarato, 100 Mg; Judicial Action - Quetiapine Hemifumarate 50 Mg; Lawsuit - Devenlafaxine, Monohydrate Succinate, 100 Mg; Judicial Action- Disvenlafaxine, Monohydrate Succinato, 50 Mg
country Brazil
posting date14 Mar 2025
deadline26 Mar 2025
Object: Electronic Auction - Acquisition Of Controlled Medicines. (Process: 25410.010853/2024-34)
country Brazil
posting date14 Mar 2025
deadline28 Mar 2025
"Delivery Of Medicinal Products For The Needs Of Clinics And Compartments Of Usbalo" Prof. Ivan Chernozemski "Ead, In Lots - Part 2"
country Bulgaria
posting date13 Mar 2025
deadline23 Apr 2025
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Oxycodone/Naloxone (Atc Code According To Who: N02Aa55)
country Germany
posting date30 Jan 2025
deadline31 Mar 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Oxycodone/Naloxone (Atc Code According To Who: N02Aa55)
country Germany
posting date29 Jan 2025
deadline31 Mar 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Oxycodone/Naloxone (Atc Code According To Who: N02Aa55)
country Germany
posting date29 Jan 2025
deadline31 Mar 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Oxycodone/Naloxone (Atc Code According To Who: N02Aa55)
country Germany
posting date29 Jan 2025
deadline31 Mar 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Oxycodone/Naloxone (Atc Code According To Who: N02Aa55)
country Germany
posting date29 Jan 2025
deadline31 Mar 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Oxycodone/Naloxone (Atc Code According To Who: N02Aa55)
country Germany
posting date29 Jan 2025
deadline31 Mar 2027
Pharmaceutical Discount Agreements For Various Active Ingredients Within The Framework Of An Open-House Procedure
country Germany
posting date12 Aug 2024
deadline03 Aug 2026
Open House Drug Discount Agreements Oxycodone And Naloxone, Atc N02Aa55
country Germany
posting date16 Apr 2024
deadline05 Apr 2026
Open House Drug Discount Agreements Oxycodone And Naloxone, Atc N02Aa55
country Germany
posting date16 Apr 2024
deadline05 Apr 2026
Medicines With The Active Ingredient Combination Oxycodone And Naloxone (Atc: N02Aa55)
country Germany
posting date21 Mar 2024
deadline28 Feb 2026
Completion Of A Non-Excl. Discount Agreement According To § 130A Paragraph 8 Sgb V For Oxycodone, Naloxone (Patent-Free Indication), Atc Code: N02Aa55 For The Period From October 1St, 2023 To September 30Th, 2025
country Germany
posting date29 Aug 2023
deadline05 Aug 2025
Completion Of A Non-Excl. Discount Agreement According To § 130A Paragraph 8 Sgb V For Oxycodone, Naloxone (Patent-Free Indication), Atc Code: N02Aa55 For The Period From October 1St, 2023 To September 30Th, 2025
country Germany
posting date28 Aug 2023
deadline05 Aug 2025
Conclusion Of Non-Exclusive Discount Agreements In Accordance With §§ 130A Paragraph 8/130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Oxycodone + Naloxone (N02Aa55) As Part Of A So-Called Open House Model.
country Germany
posting date19 May 2023
deadline30 Apr 2025
Conclusion Of Non-Exclusive Drug Discount Agreements According To § 130A Para. 8 Sgb V By Means Of A So-Called Open House Model For The Active Ingredient Oxycodone/Naloxone (Atc Code According To Who: N02Aa55)
country Germany
posting date09 Feb 2023
deadline31 Mar 2025
Conclusion Of Non-Exclusive Drug Discount Agreements According To § 130A Para. 8 Sgb V By Means Of A So-Called Open House Model For The Active Ingredient Oxycodone/Naloxone (Atc Code According To Who: N02Aa55)
country Germany
posting date06 Feb 2023
deadline31 Mar 2025

Share Share this page